Regeneron (REGN), Sanofi (SNY) Report Plans to Restructure Antibody Collaboration for Kevzara (sarilumab) and Praluent (alirocumab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. IBM
4. SPCX
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. DPZ

Go back to Regeneron (REGN), Sanofi (SNY) Report Plans to Restructure Antibody Collaboration for Kevzara (sarilumab) and Praluent (alirocumab)
Regeneron (NASDAQ: REGN) Delayed: 619.03 +6.53 (1.07%)
Previous Close $612.50    52 Week High $592.36 
Open $607.92    52 Week Low $325.35 
Day High $620.79    P/E 162.48 
Day Low $607.92    EPS $3.81 
Volume 144,757